What is BMEA's P/E ratio?

BIOMEA FUSION INC (BMEA) currently trades at a P/E ratio of 19.91.

BIOMEA FUSION INC reports a Return on Equity (ROE) of -240.13%.

What is BMEA's dividend yield?

BIOMEA FUSION INC offers a dividend yield of 0.00%.

What is BMEA's Deepscope Quality Score?

Deepscope rates BMEA's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BMEA?

Deepscope's AI Timing Score for BMEA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BMEA belong to?

BIOMEA FUSION INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น BMEA (NASDAQ) | BIOMEA FUSION INC – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-09 | FS: 2026-03-31)

BMEA

BIOMEA FUSION INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 1.14

-0.02 (-1.30%) Day Change

Watchlist Portfolio Compare Chart

19.91

P/E

0.07

D/E

-240.1%

ROE

-96.9%

ROA

0.00%

Div Yield

-1.87

PEG

BIOMEA FUSION INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.14 Price -0.02 (-1.30%) Day Change	NEWS SCORE: 99

BMEA มีคุณภาพโดยรวมยังไม่ดีนัก ( คะแนนปัจจัยพื้นฐาน = 54) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ไม่ดี , ...

ปัจจัยทางคุณภาพ

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.14
PBV / Sector	4.91 / 4.71
Earning Per Share	-0.56

PE / Sector	19.91 / 17.58
PEG or PE/Growth / Sector	-1.87 / 0.53
Average 1M Daily Value	1.54 M GREAT
Average 1W Daily Value	1.84 M GREAT

ปัจจัยทางเทคนิค

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-96.91 / 31.69
ROA Average (%) / Sector	-99.22 / -353.18
ROA Change Average (%) / Sector	35.70 / 5,214.65 GREAT
ROE (%) / Sector	-240.13 / 10.58
ROE Average (%) / Sector	-172.13 / 27.64
ROE Change Average (%) / Sector	68.53 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 3.68

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-10 09:43:12
Symbol	BMEA
Name	BIOMEA FUSION INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	72.30 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	91.82 / 8,889.42

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1599 Industrial Road, San Carlos, CA, United States, 94070

Phone: 650 980 9099

Website: https://biomeafusion.com

Sector: Healthcare >> Biotechnology

Description: Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.